| 臺大學術典藏 |
2022-01-25T02:29:53Z |
Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: the molecular mechanism and the clinical application
|
LEE JIH-HSIANG; Cheng, A-L; Lin, C-W; Kuo, S-H |
| 臺大學術典藏 |
2021-11-29T05:59:19Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
CHING-YAO YANG; Liao, Wei-Yu; Ho, Chao-Chi; Chen, Kuan-Yu; Tsai, Tzu-Hsiu; Hsu, Chia-Lin; Liu, Yi-Nan; Su, Kang-Yi; Chang, Yih-Leong; Wu, Chen-Tu; Liao, Bin-Chi; Hsu, Chia-Chi; Hsu, Wei-Hsun; LEE JIH-HSIANG; Lin, Chia-Chi; Shih, Jin-Yuan; Yang, James Chih-Hsin; Yu, Chong-Jen |
| 臺大學術典藏 |
2021-11-29T05:57:16Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M-Positive NSCLC
|
Liao, Bin-Chi; Hsu, Wei-Hsun; LEE JIH-HSIANG; CHING-YAO YANG; Tsai, Tzu-Hsiu; Liao, Wei-Yu; Ho, Chao-Chi; Lin, Chia-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Soo, Ross A; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2021-11-29T05:27:58Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M-Positive NSCLC
|
Liao, Bin-Chi; Hsu, Wei-Hsun; LEE JIH-HSIANG; Yang, Ching-Yao; TZU-HSIU TSAI; Liao, Wei-Yu; Ho, Chao-Chi; Lin, Chia-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Soo, Ross A; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2021-11-29T03:22:49Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M-Positive NSCLC
|
Liao, Bin-Chi; Hsu, Wei-Hsun; LEE JIH-HSIANG; Yang, Ching-Yao; Tsai, Tzu-Hsiu; WEI-YU LIAO; Ho, Chao-Chi; Lin, Chia-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Soo, Ross A; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2021-11-17T06:28:35Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M-Positive NSCLC
|
Liao, Bin-Chi; Hsu, Wei-Hsun; LEE JIH-HSIANG; Yang, Ching-Yao; Tsai, Tzu-Hsiu; Liao, Wei-Yu; CHAO-CHI HO; Lin, Chia-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Soo, Ross A; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2021-11-02T06:58:32Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M-Positive NSCLC
|
Liao, Bin-Chi; Hsu, Wei-Hsun; LEE JIH-HSIANG; Yang, Ching-Yao; Tsai, Tzu-Hsiu; Liao, Wei-Yu; CHAO-CHI HO; Lin, Chia-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Soo, Ross A; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2021-08-15T00:07:58Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC
|
BIN-CHI LIAO; Hsu, Wei Hsun; Lee, Jih Hsiang; Yang, Ching Yao; TZU-HSIU TSAI; WEI-YU LIAO; CHAO-CHI HO; Chia-Chi Lin; JIN-YUAN SHIH; CHONG-JEN YU; Soo, Ross A.; CHIH-HSIN YANG |
| 臺大學術典藏 |
2021-07-13T06:04:41Z |
Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer
|
LEE JIH-HSIANG; Yu C.-J.; Chen K.-Y.; Shih J.-Y.; Lin Y.-L.; Yang C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:40Z |
MicroRNA expression and clinical outcome of small cell lung cancer
|
LEE JIH-HSIANG; Voortman J.; Dingemans A.-M.C.; Voeller D.M.; Pham T.; Wang Y.; Giaccone G. |
| 臺大學術典藏 |
2021-07-13T06:04:40Z |
Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
|
Wu S.-G.; Yang C.-H.; Yu C.-J.; LEE JIH-HSIANG; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2021-07-13T06:04:40Z |
Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors
|
Voortman J.; LEE JIH-HSIANG; Killian J.K.; Suuriniemi M.; Wang Y.; Lucchi M.; Smith Jr. W.I.; Meltzer P.; Wang Y.; Giaccone G. |
| 臺大學術典藏 |
2021-07-13T06:04:39Z |
MEK inhibitors reverse resistance in epidermal growth factor receptor mutation lung cancer cells with acquired resistance to gefitinib
|
Huang M.-H.; LEE JIH-HSIANG; Chang Y.-J.; Tsai H.-H.; Lin Y.-L.; Lin A.M.Y.; Yang J.C.H. |
| 臺大學術典藏 |
2021-07-13T06:04:39Z |
Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells
|
Weng M.-T.; LEE JIH-HSIANG; Wei S.-C.; Li Q.; Shahamatdar S.; Hsu D.; Schetter A.J.; Swatkoski S.; Mannan P.; Garfield S.; Gucek M.; Kim M.K.H.; Annunziata C.M.; Creighton C.J.; Emanuele M.J.; Harris C.C.; Sheu J.-C.; Giaccone G.; Luo J. |
| 臺大學術典藏 |
2021-07-13T06:04:39Z |
Loss of 18q22.3 involving the carboxypeptidase of glutamate-like gene is associated with poor prognosis in resected pancreatic cancer
|
LEE JIH-HSIANG; Giovannetti E.; Hwang J.-H.; Petrini I.; Wang Q.; Voortman J.; Wang Y.; Steinberg S.M.; Funel N.; Meltzer P.S.; Wang Y.; Giaccone G. |
| 臺大學術典藏 |
2021-07-13T06:04:38Z |
Role of CYB5A in pancreatic cancer prognosis and autophagy modulation
|
Giovannetti E.; Wang Q.; Avan A.; Funel N.; Lagerweij T.; LEE JIH-HSIANG; Caretti V.; Van Der Velde A.; Boggi U.; Wang Y.; Vasile E.; Peters G.J.; Wurdinger T.; Giaccone G. |
| 臺大學術典藏 |
2021-07-13T06:04:38Z |
The janus kinases inhibitor AZD1480 attenuates growth of small cell lung cancers in vitro and in vivo
|
LEE JIH-HSIANG; Park K.-S.; Alberobello A.T.; Kallakury B.; Weng M.-T.; Wang Y.; Giaccone G. |
| 臺大學術典藏 |
2021-07-13T06:04:38Z |
Capillary isoelectric-focusing immunoassays to study dynamic oncoprotein phosphorylation and drug response to targeted therapies in non-small cell lung cancer
|
Chen J.-Q.; LEE JIH-HSIANG; Herrmann M.A.; Park K.-S.; Heldman M.R.; Goldsmith P.K.; Wang Y.; Giaccone G. |
| 臺大學術典藏 |
2021-07-13T06:04:37Z |
High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country
|
Lin C.-H.; Shen C.-Y.; LEE JIH-HSIANG; Huang C.-S.; Yang C.-H.; Kuo W.-H.; Chang D.-Y.; Hsiung C.-N.; Kuo K.-T.; Chen W.-W.; Chen I.-C.; Wu P.-F.; Kuo S.-H.; Chen C.-J.; Lu Y.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-13T06:04:37Z |
Enhancer of rudimentary homolog regulates DNA damage response in hepatocellular carcinoma
|
Weng M.-T.; Tung T.-H.; LEE JIH-HSIANG; Wei S.-C.; Lin H.-L.; Huang Y.-J.; Wong J.-M.; Luo J.; Sheu J.-C. |
| 臺大學術典藏 |
2021-07-13T06:04:37Z |
Characterization of fibroblast growth factor receptor 1 in small-cell lung cancer
|
Thomas A.; LEE JIH-HSIANG; Abdullaev Z.; Park K.-S.; Pineda M.; Saidkhodjaeva L.; Miettinen M.; Wang Y.; Pack S.D.; Giaccone G. |
| 臺大學術典藏 |
2021-07-13T06:04:37Z |
Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer
|
LEE JIH-HSIANG; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; Ho C.-C.; Laio W.-Y.; Yang P.-C.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:36Z |
Safety of gefitinib in non-small cell lung cancer treatment
|
Hsiue E.H.-C.; LEE JIH-HSIANG; Lin C.-C.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:36Z |
Profile of the therascreen? EGFR RGQ PCR kit as a companion diagnostic for gefitinib in non-small cell lung cancer
|
Hsiue E.H.-C.; LEE JIH-HSIANG; Lin C.-C.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:36Z |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis
|
Liao B.-C.; LEE JIH-HSIANG; Lin C.-C.; Chen Y.-F.; Chang C.-H.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H. |
